RecruitingNot ApplicableNCT07187154

The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy


Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrollment

300 participants

Start Date

May 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

1. Research methods Constructed the "Manual for Graded Management of Postoperative Symptoms of Esophageal Cancer" and developed continuous care Procedures. 2. Randomised controlled studies were conducted to verify the effects of the procedure.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • The patient is aware and able to communicate in Mandarin;
  • There are smartphones;
  • Proficient in using WeChat mini programs.
  • Patients who were scheduled for esophageal cancer resection in participating centers were eligible for inclusion.

Exclusion Criteria2

  • Have cognitive impairment or psychiatric illness;
  • Refusal to participate

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESmart Symptom Management Program

During the first six months after surgery, patients in the experimental group will use a WeChat mini-program to proactively self-report their symptoms regularly using the Chinese version of the MD Anderson Symptom Inventory for Esophageal Cancer (MDASI-EC). Based on the reported scores and the pre-defined algorithms in the "Post-Esophagectomy Symptom Grading Management Manual", the system will automatically provide personalized self-management guidance for low-grade symptoms. For more severe symptoms, the system will generate alerts to prompt dedicated study nurses to initiate proactive telephone follow-up and provide tailored health coaching.


Locations(1)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07187154


Related Trials